Eficacia de la inducción hormonal con distintas dosis de GnRHa en corvina (Argyrosomus regius)

[EN]The objective of this experiment was to determine the efficacy of different GnRHa doses for the induction of the spawning in meagre broodstock born in captivity. Five experimental groups were established, and one control group that was not injected. Fish were acclimated in six 10 m3 tanks, and in each tank there was 3? and 4? with an average weight of 8.33±0.97 and 8.47±1.09 kg respectively. Throughout the experimental period (April 14- June 2 of 2009), broodstock were induced on a weekly basis. Each time one female and two males from each of the five experimental groups were induced with an injection of GnRHa at the doses of 10, 20, 30, 40 and 50 ?g.kg-1 respectively. No significant differences were found in any of the controlled parameters: % of injected females with spawning, latency period and % of spawns. Although the highest spawning ratio was obtained with the lower doses, a statistically significant negative correlation between the doses and percentage spawning was found.

Eficacia de la inducción hormonal, con distintas dosis de GnRHa, en reproductores de corvina (Argyrosomus regius) : efecto sobre la producción y la calidad de las puestas

Máster Oficial en Cultivos Marinos. Trabajo presentado como requisito parcial para la obtención del Título de Máster Oficial en Cultivos Marinos, otorgado por la Universidad de Las Palmas de Gran Canaria (ULPGC), el Instituto Canario de Ciencias Marinas (ICCM), y el Centro Internacional de Altos Estudios Agronómicos Mediterráneos de Zaragoza (CIHEAM)

Obtención de puestas del pez de limón ("Seriola dumerili") mediante inducciones con GnRHa, aplicada con inyección e implante. Calidad de las puestas obtenidas

Máster Oficial en Cultivos Marinos. Trabajo presentado como requisito parcial para la obtención del Título de Máster Oficial en Cultivos Marinos, otorgado por la Universidad de Las Palmas de Gran Canaria (ULPGC), el Instituto Canario de Ciencias Marinas (ICCM), y el Centro Internacional de Altos Estudios Agronómicos Mediterráneos de Zaragoza (CIHEAM)

Dose-dependent effect of a single GnRHa injection on the spawning of meagre ("Argyrosomus regius") broodstock reared in captivity

[EN]The present study aimed to determine the spawning efficacy, egg quality and quantity of captive breed meagre induced with a single gonadotrophin-releasing hormone agonist (GnRHa) injection of 0, 1, 5, 10, 15, 20, 25, 30, 40 or 50 μg kg–1 to determine a recommended optimum dose to induce spawning. The doses 10, 15 and 20 μg kg–1 gave eggs with the highest quality (measured as: percentage of viability, floating, fertilisation and hatch) and quantity (measured as: total number of eggs, number of viable eggs, number of floating eggs, number of hatched larvae and number of larvae that reabsorbed the yolk sac). All egg quantity parameters were described by Gaussian regression analysis with R2 = 0.89 or R2 = 0.88. The Gaussian regression analysis identified that the optimal dose used was 15 μg kg–1. The regression analysis highlighted that this comprehensive study examined doses that ranged from low doses insufficient to stimulate a high spawning response (significantly lower egg quantities, p < 0.05) compared to 15 μg kg–1 through to high doses that stimulated the spawning of significantly lower egg quantities and eggs with significantly lower quality (egg viability). In addition, the latency period (time from hormone application to spawning) decreased with increasing doses to give a regression (R2 = 0.93), which suggests that higher doses accelerated oocyte development that in turn reduced egg quality and quantity. The identification of an optimal dose for the spawning of meagre, which has high aquaculture potential, represents an important advance for the Mediterranean aquaculture industry.

Comparación entre la calidad de puestas naturales e inducidas, mediante inyección e implante de GnRHa, del pez de limón (Seriola dumerili).

[EN]For this study, a total of 19 greater amberjack (Seriola dumerili) broodstock were used. Females with oocites bigger than 600μ, and fluent males with a mean weight of 10.72±1.22 kg, fameles, and 10.77±2.33 kg males. The experimental tanks were circular tanks of 40 m3 capacity. One of the tanks were not induced and the other two were with GnRHa, one with injections and the other by implants. Best results, in all parameters studied were with natural spawns, with a 84.37% of fertilization, 92.21% of viable eggs at 24 hours of spawn, 96.60% of hatching, 69.91% of larvae one day after hatching and 10.78% of 5 day life larvae.

Comparación entre puestas naturales e inducidas, mediante inyección e implante de GnRHa, en la producción de huevos del pez de limón (Seriola dumerili)

[EN]The number of eggs obtained in natural spawning (25.60 million) is higher than those obtained by injections (12.9 million) and implants (10.5 million). The number of eggs per female was 12.80 million, in natural spawning, and 4.30 and 3.51 million, in induced with injections and implants, respectively. In number of eggs per spawn, significant differences was observed, between natural spawns (1.11 million), and induced spawning’s (0.44 and 0.21 millions, injected and implants respectively). Significant differences was also found, in number of eggs per Kg female/spawn, between natural spawning’s (56,700 eggs), injection induced (37,200 eggs) and implants (25,200 eggs).

Obtención de puestas del pez de limón (Seriola dumerili) mediante GnRHa, comparación de la eficacia de la induccion con implante e inyección.

[EN]The three males and three females of tank 2 were induced with EV-500μg GnRHa implants, one implant (500μg) was used for the females and half that doses for males. The first injection was on the 3rd of June and the last one spawning’s the 21st of October, a total of 37 injections and 29 spawns were obtained. The first implant was introduced the 20th of June, the last spawn was on the 16th of October of the implant set the 14th, a total of 17 implants and 38 spawns were obtained. The number of spawns per induction was significantly higher (P < 0.01) in implanted females, no significant differences were found in latency period which was of 43-44 hours.

Eficacia de la inducción hormonal con GCH y GnRHa en reproductores de corvina (Argyrosomus regius).

[EN]Eighteen mature meagre (Argyrosomus regius) broodstock, born in captivity, were divided in 3 experimental groups in ratios of 3 ♀ and 3 ♂ each. One group was inducted by injections of hCG, the other with GnRHa and the last group with implants of GnRHa. In all three treatments all females responded positively to the hormonal treatment. Statistically differences were found, in the number of spawns per induction, of females induced with hCG with the GnRHa treatments. Latency period was longer in spawns from GnRHa implants, and showed statistically differences with the other two treatments.

Inducción de reproductores de corvina (Argyrosomus regius) nacidos en cautividad, mediante inyección con GCH y con GnRHa, esta aplicada además mediante implante. Efecto sobre la la calidad de las puestas

[EN]The best results in all quality parameters, were obtained in the spawns of the broodstock injected with GnRHa, having 98,7 + 1,4% of fertilized eggs, 62,24 ± 27,47 % viable eggs, 92,56 ± 17,19 % hatching and 92,73 ± 10,52 % 3 day old larvae after hatching. Percentage of viable eggs was lower in the spawns of the broomstick injected with hCG, and had significant differences when compared with GnRHa broodstock treatments. 3 day old larvae and hatchings, obtained from the broomstock injected with GnRHa showed significant differences to the rest of the hormonal treatments.

Regression of the inflammatory microenvironment of the peritoneal cavity in women with endometriosis by GnRHa treatment.

OBJECTIVE To investigate the effect of gonadotropin-releasing hormone analogues (GnRHa) on the peritoneal fluid microenvironment in women with endometriosis. STUDY DESIGN Peritoneal fluid was collected from 85 women with severe endometriosis (rAFS stage III and IV) during laparoscopic surgery during the proliferative phase. Prior to surgery clinical data were collected. The concentrations of specific markers for endometriosis in the peritoneal fluid were determined using an ELISA and a comparison between peritoneal fluid markers in women using GnRHa and no hormonal treatment was performed using a non-parametric Mann-Whitney U test. RESULTS The study included peritoneal fluid from 39 patients who had been administered GnRHa (Zoladex(®)) in the three months prior to surgery and 46 from women with no hormonal treatment in this period. Concentrations of IL-8, PAPP-A, glycodelin-A and midkine were significantly reduced in the GnRHa treatment group compared to women receiving no hormonal treatment. RANTES, MCP-1, ENA-78, TNF-α, OPG, IP-10 and defensin showed no significant change between the two groups. CONCLUSIONS GnRHa mediate a significant regression in the inflammatory nature of the peritoneal microenvironment in women with endometriosis.

Effectiveness of the Combined Recombinant Human Growth Hormone and Gonadotropin-Releasing Hormone Analog Therapy in Pubertal Patients with Short Stature due to SHOX Deficiency

Context: Isolated heterozygous SHOX defects are the most frequent monogenic cause of short stature, and combined therapy with recombinant human GH (rhGH) and GnRH analog (GnRHa) in pubertal patients has been suggested, but there are no data on final height. Objective: The aim of the study was to analyze adult height after rhGH and GnRHa therapy in patients with SHOX haploinsufficiency. Patients: Ten peripubertal patients with isolated SHOX defects participated in the study. Intervention: Five patients were followed without treatment, and five were treated with rhGH (50 mu g/kg/d) and depot leuprolide acetate (3.75 mg/month). Main Outcome Measures: Adult height SD score (SDS) was measured. Results: All patients followed without treatment had marked downward growth shift during puberty (height SDS, -1.2 +/- 0.7 at 11.4 +/- 1.4 yr; adult height SDS, -2.5 +/- 0.5). Conversely, four of five patients treated with rhGH for 2 to 4.9 yr associated to GnRHa for 1.4 to 5.8 yr improved their height SDS from -2.3 +/- 1.3 at 11.8 +/- 2.1 yr to a final height SDS of -1.7 +/- 1.6. The difference between the mean height SDS at the first evaluation and final height SDS was statistically significant in nontreated vs. treated patients (mean height SDS change, -1.2 +/- 0.4 vs. 0.6 +/- 0.4, respectively; P < 0.001). Conclusion: A gain in adult height of patients with isolated SHOX defects treated with combined rhGH and GnRHa therapy was demonstrated for the first time, supporting this treatment for children with SHOX defects who have just started puberty to avoid the loss of growth potential observed in these patients during puberty. (J Clin Endocrinol Metab 95: 328-332, 2010)